Synthesis of Therapeutic Agents The promoter used for cloning HBV surface antigen is β-galactosidase alcohol dehydrogenase 1 galactokinase polyhedrin β-galactosidase alcohol dehydrogenase 1 galactokinase polyhedrin ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents Recombinant vaccine for HBV was produced by cloning viral genes in autonomously replicating plasmid of yeast plasmids phagemids cosmids autonomously replicating plasmid of yeast plasmids phagemids cosmids ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents Chemically synthesized DNA sequences for the two chains are separately inserted into the plasmid pBR 322 by the side of β-Galactosidase glucokinase galactokinase acid phosphatase β-Galactosidase glucokinase galactokinase acid phosphatase ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents Human insulin formed by recombinant DNA technology is known as H insulin R insulin humulin huinsulin H insulin R insulin humulin huinsulin ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents In India first genetically engineered vaccine against HBV was developed by Dabur Pvt Ltd Glaxo Pvt Ltd Ranbaxy Pvt Ltd Shantha Biotechnics Pvt Ltd Dabur Pvt Ltd Glaxo Pvt Ltd Ranbaxy Pvt Ltd Shantha Biotechnics Pvt Ltd ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents The two chains of insulin can be separated by detaching it from β-galactosidase using protease hydrogen chloride cyanogen bromide peptidase protease hydrogen chloride cyanogen bromide peptidase ANSWER DOWNLOAD EXAMIANS APP
EXAMIANS